Drug Type Therapeutic vaccine |
Synonyms Autologous dendritic cellderived exosomes, DEX |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Phase 2 | United States | - | - |
Melanoma | Phase 2 | Europe | - | - |
Non-Small Cell Lung Cancer | Phase 1 | United States | - | |
Colorectal Cancer | Preclinical | United States | - | - |
Pancreatic Cancer | Preclinical | United States | - | - |
Prostatic Cancer | Preclinical | United States | - | - |
Uterine Cervical Cancer | Preclinical | United States | - | - |
Not Applicable | Uveitic Macular Edema ellipsoid zone (EZ) damage | disorganization of retinal inner layers (DRIL) | epiretinal membrane (ERM) | 58 | dszcgqkmfc(nqcgccdvuz) = rrmfjvojlc ttioiqmvzf (iaacrzqdmd ) View more | Positive | 05 Oct 2023 | ||
Not Applicable | - | Concurrent DEX and ranibizumab injections | ekyanwarfh(bchxtsrvts) = one patient in the study group had an elevated IOP of 10mmHg at two months postoperatively. Five patients (38.5%) in the study group received medical treatment that successfully retarded IOP elevation. In the control group, there were no significant fluctuations concerning BCVA, CMT, and IOP and no ocular hypertension was observed. pzcbyugdhb (ebinkmodof ) | - | 23 Feb 2023 | ||